Frontlight ResearchEarly access
Childhood cancers trials in China
609 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseEnrolling by invitationDa Qing Offspring Study
- Where
- Beijing
- People
- 5,000
- Run by
- China-Japan Friendship Hospital
See details and how to joinNCT06958640 - No phaseTaking peoplePatient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer
- Where
- Beijing
- Age
- 17 years to 45 years
- People
- 244
- Run by
- Peking University People's Hospital
See details and how to joinNCT05647109 - Phase 2Taking peopleProgesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
- Where
- Beijing
- Age
- 17 years to 45 years
- People
- 38
- Run by
- Peking University People's Hospital
See details and how to joinNCT06102863 - No phaseTaking peopleA Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China
- Where
- Guangzhou
- People
- 1,000
- Run by
- Guangzhou Medical University
See details and how to joinNCT06718972 - No phaseTaking peopleRituximab, Methotrexate, and Tepadina Induction Followed by Etoposide and Cytarabine Consolidation in Primary Central Nervous System Lymphoma
- Where
- Changchun
- Age
- Up to 60 years
- People
- 41
- Run by
- FengYan Jin
See details and how to joinNCT06946407 - No phaseTaking peopleRaman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
- Where
- Hangzhou, Nanchang, Shanghai
- People
- 600
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06822413 - No phaseTaking peopleNon-Helium Magnetoencephalography in Pediatric Brain Tumors
- Where
- Guangzhou
- Age
- 3 years to 18 years
- People
- 100
- Run by
- Guangzhou Women and Children's Medical Center
See details and how to joinNCT06943742 - No phaseTaking peopleCorrelation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma
- Where
- Zhengzhou
- People
- 200
- Run by
- Henan Cancer Hospital
See details and how to joinNCT04263935 - Phase 2Taking peopleArsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M Neuroblastoma
- Where
- Guangzhou
- Age
- 18 months to 18 years
- People
- 92
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06933394 - No phaseTaking peopleObservational Clinical Study on Role of MRD in Predicting Local Therapy in Oligometastatic Breast Cancer
- Where
- Changchun
- People
- 40
- Run by
- The First Hospital of Jilin University
See details and how to joinNCT06918262 - No phaseTaking peopleScreening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis
- Where
- Guangzhou
- People
- 200
- Run by
- Zhujiang Hospital
See details and how to joinNCT05686447 - Phase 2Taking peopleTamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas
- Where
- Shanghai
- Age
- 14 years to 80 years
- People
- 30
- Run by
- Fudan University
See details and how to joinNCT06914674 - No phaseTaking peopleSleep Disordered Breathing and Multimorbidity: The Xiangya SDB Cohort Study
- Where
- Changsha
- People
- 15,000
- Run by
- Xiangya Hospital of Central South University
See details and how to joinNCT06755840 - Phase 4Taking peopleDose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease
- Where
- Tanjin, Xuzhou
- Age
- 1 day to 18 years
- People
- 1,500
- Run by
- Wei Zhao
See details and how to joinNCT03844360 - Phase 2Not yet taking people in ChinaSelinexor Combined With Azacitidine Therapy in High-Risk Myeloid Neoplasms Patients
- Where
- Tianjin
- Age
- 16 years to 75 years
- People
- 20
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06900088 - No phaseTaking peopleBiomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion Therapy
- Where
- Shanghai
- People
- 240
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT06382103 - Phase 2Not yet taking people in ChinaGP Combined with Toripalimab Versus GP Induction Chemotherapy for Advanced Childhood Nasopharyngeal Carcinoma
- Where
- Guangzhou
- Age
- 6 years to 18 years
- People
- 72
- Run by
- Sun Yat-sen University
See details and how to joinNCT06605131 - No phaseTaking peopleAnalysis of Exploring Optimized Sequential Treatment Strategies of Antibody-Drug Conjugates (ADCs) in HER2-Low-Expressing Breast Cancer
- Where
- Guangzhou
- People
- 700
- Run by
- Sun Yat-sen University
See details and how to joinNCT06877416 - No phaseTaking peopleA Single-arm, Prospective Study of TBI + BUMEL As a Conditioning Regimen for Salvage HSCT in Patients with R/R AML
- Where
- Suzhou
- Age
- 14 years to 70 years
- People
- 40
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT06879847 - No phaseNot yet taking people in ChinaValidation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China
- Where
- Guiyang
- Age
- 5 years to 16 years
- People
- 360
- Run by
- RenJi Hospital
See details and how to joinNCT06873672 - No phaseTaking peopleBridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia
- Where
- Beijing
- Age
- 12 years to 65 years
- People
- 130
- Run by
- Peking University People's Hospital
See details and how to joinNCT06581081 - Phase 2Not yet taking people in ChinaEffectiveness and Safety of InO±DLI for Relapsed B-ALL/LBL After Allo-HSCT
- Where
- Hangzhou
- Age
- 14 years to 65 years
- People
- 23
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT06861348 - Phase 2Taking peopleClinical Study on the Safety, Efficacy and Pharmacokinetics of Telpegfilgrastim in Pediatric Cancer Patients with Chemotherapy
- Where
- Guangzhou
- Age
- 14 years to 18 years
- People
- 97
- Run by
- Sun Yat-sen University
See details and how to joinNCT06857292 - Phase 2Taking peopleSintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: A Phase II Study
- Where
- Guangzhou
- Age
- 1 year to 18 years
- People
- 73
- Run by
- Sun Yat-sen University
See details and how to joinNCT06848569 - No phaseTaking peopleUmbilical Cord Blood NK Cell Therapy for High-Risk Pediatric Soft Tissue Sarcoma: Efficacy and Safety Study
- Where
- Dongguan, Guangzhou
- Age
- Up to 18 years
- People
- 40
- Run by
- Sun Yat-sen University
See details and how to joinNCT06848582